BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 33933007)

  • 1. Clinical and therapeutic features and prognostic factors of metastatic colorectal cancer over age 80: a retrospective study.
    Hisada H; Takahashi Y; Kubota M; Shimura H; Itobayashi E; Shimura K; Nakamura A
    BMC Gastroenterol; 2021 May; 21(1):199. PubMed ID: 33933007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of selected inflammation-based prognostic markers in relapsed or refractory metastatic colorectal cancer patients.
    Song A; Eo W; Lee S
    World J Gastroenterol; 2015 Nov; 21(43):12410-20. PubMed ID: 26604648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival and prognostic association in stage IV colorectal cancer patients treated with chemotherapy in Bangladesh.
    Shuayb M; Mehedi Hasan M; Hoque MR; Mushtaq Hussain Q; Begum R; Reza MS
    Jpn J Clin Oncol; 2021 Apr; 51(4):552-559. PubMed ID: 33341898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of Metastatic Colorectal Cancer Patients ≥75 Years Old in Clinical Practice: A Multicenter Analysis.
    Grande R; Natoli C; Ciancola F; Gemma D; Pellegrino A; Pavese I; Garufi C; Di Lauro L; Corsi D; Signorelli D; Sperduti I; Cortese G; Risi E; Morano F; Sergi D; Signorelli C; Ruggeri EM; Zampa G; Russano M; Gamucci T
    PLoS One; 2016; 11(7):e0157751. PubMed ID: 27442239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical efficacy of chemotherapy in colorectal cancer patients over 80 years old.
    Zhang D; Wang X; Zhang M; Yin Y; Guo J
    Int J Colorectal Dis; 2022 Aug; 37(8):1853-1863. PubMed ID: 35857106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survival Outcomes in Patients With RAS Wild Type Metastatic Colorectal Cancer Classified According to Köhne Prognostic Category and BRAF Mutation Status.
    Siena S; Rivera F; Taieb J; Peeters M; Prenen H; Koukakis R; Demonty G; Köhne CH
    Clin Colorectal Cancer; 2018 Mar; 17(1):50-57.e8. PubMed ID: 29096990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Prognostic Impact of KRAS G12C Mutation in Patients with Metastatic Colorectal Cancer: A Multicenter Retrospective Observational Study.
    Chida K; Kotani D; Masuishi T; Kawakami T; Kawamoto Y; Kato K; Fushiki K; Sawada K; Kumanishi R; Shirasu H; Matsubara Y; Yuki S; Komatsu Y; Yamazaki K; Yoshino T
    Oncologist; 2021 Oct; 26(10):845-853. PubMed ID: 34232546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multicenter retrospective analysis of metastatic colorectal cancer (CRC) with high-level microsatellite instability (MSI-H).
    Goldstein J; Tran B; Ensor J; Gibbs P; Wong HL; Wong SF; Vilar E; Tie J; Broaddus R; Kopetz S; Desai J; Overman MJ
    Ann Oncol; 2014 May; 25(5):1032-8. PubMed ID: 24585723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Geriatric Nutritional Risk Index is a prognostic marker in patients with metastatic colorectal cancer.
    Kato R; Miyamoto Y; Ouchi M; Ogawa K; Yoshida N; Baba H
    Int J Clin Oncol; 2023 Jul; 28(7):893-900. PubMed ID: 37072628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating tumor cells as an independent prognostic factor in advanced colorectal cancer: a retrospective study in 121 patients.
    Wang L; Zhou S; Zhang W; Wang J; Wang M; Hu X; Liu F; Zhang Y; Jiang B; Yuan H
    Int J Colorectal Dis; 2019 Apr; 34(4):589-597. PubMed ID: 30627849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinicopathological features of HER2 positive metastatic colorectal cancer and survival analysis of anti-HER2 treatment.
    Yang L; Li W; Lu Z; Lu M; Zhou J; Peng Z; Zhang X; Wang X; Shen L; Li J
    BMC Cancer; 2022 Apr; 22(1):355. PubMed ID: 35365123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased mean platelet volume predicts poor prognosis in metastatic colorectal cancer patients treated with first-line chemotherapy: results from mCRC biomarker study.
    Chang J; Lin G; Ye M; Tong D; Zhao J; Zhu D; Yu Q; Zhang W; Li W
    BMC Cancer; 2019 Jan; 19(1):15. PubMed ID: 30612568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Age-dependent differences in first-line chemotherapy in patients with metastatic colorectal cancer: the DISCO study.
    Lund CM; Vistisen KK; Dehlendorff C; Rønholt F; Johansen JS; Nielsen DL
    Acta Oncol; 2018 Nov; 57(11):1445-1454. PubMed ID: 30375911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain Metastasis in Colorectal Cancer Patients: Survival and Analysis of Prognostic Factors.
    Michl M; Thurmaier J; Schubert-Fritschle G; Wiedemann M; Laubender RP; Nüssler NC; Ruppert R; Kleeff J; Schepp W; Reuter C; Löhe F; Karthaus M; Neumann J; Kirchner T; Engel J; Heinemann V
    Clin Colorectal Cancer; 2015 Dec; 14(4):281-90. PubMed ID: 26123495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using nomograms to predict prognostic factors in young colorectal mucinous and signet-ring cell adenocarcinoma patients.
    Wang B; Zeng J; Liu Y
    Biosci Rep; 2019 Jul; 39(7):. PubMed ID: 30692229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prognostic factors of patients with unresectable liver metastasis from colorectal cancer after failed conversion chemotherapy].
    He H; Shen W; Chen W; Liu H; Gong W; Fu J; Hu X; Cui L
    Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Nov; 21(11):1261-1267. PubMed ID: 30506537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of Predictive Value of the Modified Glasgow Prognostic Score for Later-line Chemotherapy in Patients With Metastatic Colorectal Cancer.
    Tsuchihashi K; Ito M; Moriwaki T; Fukuoka S; Taniguchi H; Takashima A; Kumekawa Y; Kajiwara T; Yamazaki K; Esaki T; Makiyama A; Denda T; Satake H; Suto T; Sugimoto N; Katsumata K; Ishikawa T; Kashiwada T; Oki E; Komatsu Y; Okuyama H; Sakai D; Ueno H; Tamura T; Yamashita K; Kishimoto J; Shimada Y; Baba E
    Clin Colorectal Cancer; 2018 Dec; 17(4):e687-e697. PubMed ID: 30149986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prognostic value of the prognostic nutritional index in patients with metastatic colorectal cancer.
    Ucar G; Ergun Y; Acikgoz Y; Uncu D
    Asia Pac J Clin Oncol; 2020 Oct; 16(5):e179-e184. PubMed ID: 32301263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcome of chemotherapy with or without targeted agents in metastatic colorectal cancer patients with deficient DNA mismatch repair: A single center, cohort study.
    Yu Y; Ying J; Zhang W; Li W; Sun Y; Yang L; Cui C; Zeng Y; Zhou A
    Asia Pac J Clin Oncol; 2019 Jun; 15(3):128-135. PubMed ID: 30693649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics and prognosis of gastric cancer in patients aged ≥ 70 years.
    Liang YX; Deng JY; Guo HH; Ding XW; Wang XN; Wang BG; Zhang L; Liang H
    World J Gastroenterol; 2013 Oct; 19(39):6568-78. PubMed ID: 24151383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.